Skip to main content
CHC logo

CHC — Investor Relations & Filings

Ticker · 4164 ISIN · TW0004164009 TW Wholesale and retail trade
Filings indexed 2,275 across all filing types
Latest filing 2018-04-11 Director's Dealing
Country TW Taiwan
Listing TW 4164

About CHC

www.chcg.com

CHC Healthcare Group is a provider of comprehensive medical equipment, technology, and management services. The company offers one-stop solutions ranging from equipment distribution and leasing to operational consulting and hospital management. Its extensive portfolio covers specialized fields such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, dentistry, and rehabilitation. Representing over 30 international brands, the group is a major distributor of high-end medical devices and a leader in oncology equipment. Beyond equipment sales and maintenance, the company has expanded into long-term care, radiation sterilization services, and chain pharmacy channels. With a focus on smart healthcare and advanced medical technologies, the group supports healthcare providers through technical maintenance, personnel training, and integrated department construction across the Asia-Pacific region.

Recent filings

Filing Released Lang Actions
107年03月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and stock ownership information of company insiders, including directors, general managers, and other executives. It includes data on shares held, changes in holdings, and related notes. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions by company directors and executives (insider trades). Therefore, it fits the category 'Director's Dealing' (DIRS). The document length is sufficient and the content is substantive insider shareholding data, not a mere announcement or certification.
2018-04-11 Chinese
107年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document contains financial data related to loan balances, endorsements, and guarantees for a company and its subsidiaries for a specific month (March of the 107th year in the ROC calendar, which corresponds to 2018). The data is presented in a tabular format with monetary amounts and limits. The document is very short (671 characters) and does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of financial guarantees and loan balances rather than a full financial report or announcement of a meeting or voting results. There is no indication of an earnings release, management discussion, or audit report. Given the nature of the data and the short length, this fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2018-04-10 Chinese
107年3月營業收入
Regulatory Filings Classification · 95% confidence The document is a brief tabular summary listing company codes and names, with a note about monthly revenue reporting by subsidiaries under ROC or IFRS standards. It contains no financial statements, no detailed report content, no regulatory announcements, no voting results, no management or board information, and no mention of any specific report or filing. The document length is very short (629 characters), and it appears to be a general regulatory or informational filing without substantive financial or corporate event data. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories.
2018-04-10 Chinese
107年04月法人說明會簡報 — 416420180410E001.pdf
Investor Presentation Classification · 95% confidence The document is titled 'Performance Presentation for Biotechnology and Medical Care Industry (2018.04.11) 4164 TT' and contains detailed company information, operational results, financial data including annual results, monthly sales, and future guidance. It includes a company introduction, milestones, board of directors, product mix, and financial performance metrics such as operating revenue, gross profit, net profit, and EPS. The presence of forward-looking statements and detailed financial and operational data indicates this is a presentation aimed at investors or stakeholders summarizing company performance and outlook. The document is about 15,000 characters long, which is consistent with a detailed presentation rather than a brief announcement. The content and format align with an Investor Presentation (IP) rather than an Annual Report (10-K) or Earnings Release (ER), as it includes operational overview, results, and future guidance in a presentation format with slides and disclaimers. Therefore, the most appropriate classification is Investor Presentation (IP).
2018-04-10 Chinese
107年04月法人說明會簡報 — 416420180410M001.pdf
Investor Presentation Classification · 95% confidence The document is a detailed presentation titled '生技醫療主題式業績發表會(2018.04.11)' which translates to 'Biotech Medical Thematic Performance Presentation (April 11, 2018)'. It includes company overview, financial performance data, future outlook, product portfolio, market analysis, and strategic plans. The content is structured as a presentation with slides, including disclaimers, company milestones, board members, financial charts, and market forecasts. There is no indication that this is an official annual or quarterly report, audit report, or regulatory filing. It is not a transcript of a call, nor an announcement of voting results or capital changes. The document is clearly a detailed investor or stakeholder presentation focusing on financials, strategy, and market position. Therefore, the most appropriate classification is Investor Presentation (IP). The document length (over 14,000 characters) and detailed content support this classification with high confidence.
2018-04-10 Chinese
107年04月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting, including date, time, location, and links to presentation materials. It is not a full report but rather information about a presentation event and related materials. The presence of terms like '法人說明會' (investor presentation) and links to presentation PDFs indicates this is an Investor Presentation (IP). The document length is short and it provides details about the presentation rather than financial statements or regulatory filings. Therefore, the correct classification is Investor Presentation (IP).
2018-04-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.